Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for OKAI.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2024 0.107M
June 30, 2024 0.1939M
March 31, 2024 0.5425M
December 31, 2023
September 30, 2023 18.70M
June 30, 2023 18.87M
March 31, 2023 0.0127M
December 31, 2022 0.0055M
September 30, 2022 0.013M
June 30, 2022 0.2285M
March 31, 2022 0.0335M
December 31, 2021 0.0447M
September 30, 2021 0.0729M
June 30, 2021 0.0911M
March 31, 2021 0.113M
December 31, 2020 0.1332M
September 30, 2020 0.1625M
June 30, 2020 0.1781M
March 31, 2020 0.2139M
December 31, 2019 0.218M
September 30, 2019 0.2323M
June 30, 2019 0.2563M
March 31, 2019 0.2794M
December 31, 2018 0.2993M
Date Value
September 30, 2018 0.323M
June 30, 2018 0.3509M
March 31, 2018 0.3772M
December 31, 2017 0.4064M
September 30, 2017 0.4207M
June 30, 2017 0.4783M
March 31, 2017 0.6147M
December 31, 2016 0.0121M
September 30, 2016 0.0176M
June 30, 2016 0.0171M
March 31, 2016 0.0272M
December 31, 2015 0.0439M
September 30, 2015 0.0424M
June 30, 2015 0.0746M
March 31, 2015 0.0857M
December 31, 2014 0.085M
September 30, 2014 0.092M
June 30, 2014 0.1217M
March 31, 2014 0.2159M
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013 13.41M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Diagnos, Inc. 2.390M
Arch Biopartners, Inc. 0.4632M
Avricore Health, Inc. 0.5844M
Kane Biotech, Inc. 1.811M
CardioComm Solutions, Inc. 0.155M